Evidence map›Paper›PMID 34111977›Full record

Observational studyThe British journal of radiology2022

The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient.

Steve Connor, Mustafa Anjari, Christian Burd, Amrita Guha, Mary Lei, Teresa Guerrero-Urbano, Irumee Pai, Paul Bassett, Vicky Goh

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in The British journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Steve ConnorSchool of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College, London, United Kingdom.ORCID 0000-0001-5502-4972
Mustafa AnjariDepartment of Radiology, Guy's Hospital, London, United Kingdom.
Christian BurdDepartment of Radiology, Guy's Hospital, London, United Kingdom.
Amrita GuhaDepartment of Radio-diagnosis, Tata Memorial Hospital, Parel, Homi Bhabha National Institute, Mumbai, India.
Mary LeiDepartment of Oncology, Guy's Hospital, London, United Kingdom.
Teresa Guerrero-UrbanoDepartment of Oncology, Guy's Hospital, London, United Kingdom.
Irumee PaiSchool of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College, London, United Kingdom.
Paul BassettFreelance Medical Statistician, London, United Kingdom.
Vicky GohSchool of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College, London, United Kingdom.
Guy's Hospital · GBHomi Bhabha National Institute · INSt Thomas' Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the impact of Human Papilloma Virus (HPV) oropharyngeal cancer (OPC) status on the prediction of head and neck squamous cell cancer (HNSCC) chemoradiotherapy (CRT) outcomes with pre-treatment quantitative diffusion-weighted magnetic resonance imaging (DW-MRI).

methodsFollowing ethical approval, 65 participants (53 male, age 59.9 ± 7.86) underwent pre-treatment DW-MRI in this prospective cohort observational study. There were 46 HPV OPC and 19 other HNSCC cases with Stage III/IV HNSCC. Regions of interest (ROIs) (volume, largest area, core) at the primary tumour (

resultsOn univariate analysis of all participants, the primary tumour area ADC

conclusionKnowledge of HPV OPC status is required in order to determine the impact of the pre-treatment ADC values on post-CRT outcomes in HNSCC. ADVANCES IN KNOWLEDGE: Pre-treatment ADC

Indexed as

AlphapapillomavirusChemoradiotherapyLymph NodesCisplatinDiffusion Magnetic Resonance ImagingDisease-Free SurvivalFemaleGadoliniumHumansLogistic ModelsMaleMiddle AgedNeoplasm Recurrence, LocalOropharyngeal NeoplasmsPapillomavirus InfectionsPositron Emission Tomography Computed TomographyCisplatinGadoliniumRadiation-Sensitizing Agents

Identifiers

PMID34111977
PMCPMC8822554
OpenAlexW3166709133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.